Orin Green Financial’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$388K Hold
1,992
0.14% 62
2026
Q1
$447K Buy
1,992
+14
+0.7% +$3.49K 0.18% 57
2025
Q4
$476K Hold
1,978
0.19% 55
2025
Q3
$541K Hold
1,978
0.22% 53
2025
Q2
$510K Hold
1,978
0.22% 55
2025
Q1
$417K Buy
+1,978
New +$462K 0.2% 56
2024
Q4
Sell
-2,010
Closed -$484K 56
2024
Q3
$491K Hold
2,010
0.21% 53
2024
Q2
$385K Buy
+2,010
New +$408K 0.18% 57
2024
Q1
Sell
-2,067
Closed -$379K 56
2023
Q4
$360K Sell
2,067
-28
-1% -$4.3K 0.18% 55
2023
Q3
$310K Hold
2,095
0.17% 55
2023
Q2
$458K Hold
2,095
0.24% 46
2023
Q1
$459K Sell
2,095
-586
-22% -$127K 0.25% 47
2022
Q4
$558K Buy
+2,681
New +$589K 0.33% 41

Other funds holding RMD

Orin Green Financial's RMD Position: Q2 2026 in Review

Orin Green Financial held its ResMed (RMD) position steady in Q2 2026 at 1,992 shares worth $388K. The position accounts for 0.14% of the portfolio, ranked #62.

Orin Green Financial first reported a position in RMD in Q4 2022 and has held it in 13 quarters since. The position peaked at $558K in Q4 2022. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Orin Green Financial held 1,992 shares of ResMed worth $388K as of Q2 2026.
  • Orin Green Financial left its ResMed share count unchanged in Q2 2026.
  • ResMed made up 0.14% of Orin Green Financial's portfolio in Q2 2026, its #62 holding.
  • Orin Green Financial first reported a position in ResMed in Q4 2022 and has held it in 13 quarters since.
  • Orin Green Financial's ResMed position peaked at $558K in Q4 2022.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Orin Green Financial's 13F filing for Q2 2026, filed 13 Jul 2026.